COPD
A research program dedicated to studying and treating chronic lung disease through advanced diagnostics, respiratory imaging, and investigational therapies aimed at improving breathing and long-term lung health.
The COPD Study focuses on patients living with Chronic Obstructive Pulmonary Disease, a progressive condition that makes it difficult to breathe due to airway obstruction and lung inflammation. This research aims to test new therapies, monitor lung function, and develop treatments that improve respiratory performance and overall quality of life.
1. Pulmonary Function Testing
Measures lung capacity, airflow, and oxygen exchange efficiency.
Helps determine the severity of airway obstruction and track breathing improvement during treatment.
2. Respiratory Imaging and Analysis
Uses X-rays, CT scans, or MRI to assess lung structure and detect airway damage.
Provides visual insights into inflammation and tissue changes over time.
3. Symptom and Quality-of-Life Evaluation
Monitors coughing, shortness of breath, and exercise tolerance.
Tracks how new treatments impact day-to-day comfort and respiratory endurance.
4. Investigational Drug and Therapy Trials
Tests innovative medications, inhalers, or biological therapies designed to reduce inflammation and improve airflow.
Continuous medical supervision ensures participant safety and treatment accuracy.
Eligible Participants Are
40 to 80 years of age
Diagnosed with Chronic Obstructive Pulmonary Disease (COPD)
Current or former smoker with significant smoking history
Experiencing chronic cough, shortness of breath, or frequent respiratory symptoms
Willing to undergo pulmonary function tests and imaging assessments
Additional criteria apply
Eligible Participants May
Receive study-related medical care and treatment at no cost
Receive compensation for study-related time and travel
Gain access to investigational COPD therapies and respiratory support
Contribute to advancing respiratory medicine and lung disease research
The COPD Clinical Trial plays a key role in advancing respiratory medicine and improving the management of chronic lung diseases. Participants help researchers discover effective solutions to enhance lung function and reduce symptoms associated with COPD.